SCHEMBL6073371

SCHEMBL6073371

COc1ccc2c(n1)C(C)(C)C(=O)N2C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.37
SCN9A Q15858 4/20 0.35
IDH1 O75874 2/20 0.35
MAPT P10636 1/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
BRD9 Q9H8M2 1/20 0.34
BRD7 Q9NPI1 1/20 0.34
PRKDC P78527 1/20 0.33
MTNR1A P48039 2/20 0.33
MTNR1B P49286 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
NNMT P40261 1/20 0.32
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6073645 0.74 IDH1 (0.35) POLBIDH1MAPTBRD9BRD7
SCHEMBL6074131 0.71 PRKDC (0.34) POLBMAPTPDE4APDE4BPDE4C
SCHEMBL6074263 0.69 PRKDC (0.33) POLBPRKDCMEN1KMT2ATDP1
SCHEMBL6074106 0.68 PRKDC (0.32) POLBPRKDC
SCHEMBL24251720 0.67 PGR (0.39) POLBMAPTPDE4APDE4BPDE4C
SCHEMBL6073495 0.65 CYP11B2 (0.42) POLBBRD9BRD7
SCHEMBL11167487 0.64 PDE10A (0.34) MAPTPDE4APDE4DMTNR1AMTNR1B
SCHEMBL3483987 0.63 MGLL (0.42) POLBMAPTMEN1KMT2ABACE1
SCHEMBL21513353 0.63 PRKDC (0.37) PRKDC
SCHEMBL9591238 0.63 LMNA (0.50) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 POLB 2266/4885SCN9A 1170/4885IDH1 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.